Sanjeev Bahl

Sanjeev Bahl has extensive experience in quality and operations management. Sanjeev currently holds the role of SVP, Quality at Keros Therapeutics since 2023. Prior to this, they served as SVP, Quality at Spectrum Pharmaceuticals, Inc. from 2019 to 2023, and as VP, Quality from 2019 to 2020. From 2017 to 2019, they were VP, Quality and R&D at AmerisourceBergen. Before that, they held various roles at Shire from 2016 to 2017, including VP, Head of Global Quality Systems, where they oversaw Corporate Programs and Quality Management Systems. From 2001 to 2016, Sanjeev worked at Baxter International Inc., where they served as VP, Corporate Compliance & Quality Systems, VP, Quality Operations (Global Plasma Quality Operations), VP, Quality Operations (North American Quality Operations), Sr. Director, Quality Operations, Director, Quality Operations, Director, Regulatory Compliance & Release, and Associate Director, Quality Systems & Compliance. Sanjeev also has additional experience at Morton Grove Pharmaceuticals, where they held roles such as Senior Director, Quality Control Systems and Director, Quality Assurance. Throughout their career, Sanjeev has demonstrated a focus on maintaining compliance, implementing quality systems, and overseeing quality operations in the pharmaceutical industry.

Sanjeev Bahl holds a Master of Science (M.Sc.) (Honors) in Biophysics from Panjab University. The specific start and end year of their education at this institution are not provided.